BackImmunogen Overview

Immunogen Long Term Debt

Track Immunogen's long-term debt ($72M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$72.11M

Peer average

Loading

Immunogen Long Term Debt History

Loading

Immunogen vs. peers: Long Term Debt Comparison

Loading

Immunogen Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immunogen (IMGN) FAQ

Immunogen (IMGN) currently reports a long-term debt of $72M as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Immunogen's long-term debt history and peer comparisons.

Immunogen's long-term debt changed from $0 to $72M (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immunogen reported $72M in long-term debt as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $72M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunogen, and consider following IMGN for alerts when major investors trade the stock.

Immunogen is classified in the Healthcare sector. On long-term debt, it currently shows $72M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMGN with unrelated industries.